In the final part of Professional Adviser's series on group protection, Paul Avis, sales and marketing director at Canada Life Group Insurance, explains how advisers can convince sceptical clients of the value of critical illness cover.
In this series we have looked at group income protection (GIP) and group life assurance (GLA), and so in this third and final article we turn our attention to group critical illness (GCI). This is perhaps the most exciting product, as even in the last four years of indifferent market performance, the GCI product has had positive market growth and, in 2011, showed an impressive 9% increase in premiums. This growth has been encouraged by an alignment with flexible benefit schemes, perhaps illustrating its value to employees – after all most of us know someone who has had cancer or perha...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes